Skip to Content

X 23 (Alfuzosin hydrochloride extended release 10 mg)

Pill imprint X 23 has been identified as Alfuzosin hydrochloride extended release 10 mg.

Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not a controlled substance under the Controlled Substance Act (CSA).

Alfuzosin hydrochloride extended release 10 mg X 23
Discount Card Promo
Alfuzosin hydrochloride extended release
X 23
10 mg
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Aurobindo Pharma Limited

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.